Business Week Ranks PolyMedica #20 Among Its 100 Hot Growth Companies.

Business Editors

WOBURN, Mass.--(BUSINESS WIRE)--June 3, 2002

PolyMedica Corporation (NNM: PLMD) today announced that it has been included for the first time in Business Week's "Hot Growth Companies" as reported in its June 10 issue.

PolyMedica was ranked number 20 of the top 100 companies in Business Week's annual scoreboard. Companies were measured based on their composite three-year sales and earnings growth and return on total capital.

Commenting on Business Week's listing, PolyMedica Chairman and CEO Steven J. Lee said: "Business Week's recognition of PolyMedica is further evidence that our direct-to-consumer business serving chronically-ill seniors with diabetes and respiratory disease is both scalable and effective. To date, our Company has reported 23 consecutive quarters of revenue growth over comparable periods. National surveys show that approximately one in five Medicare-eligible seniors has diabetes and that this rate of incidence is increasing. To address these needs, we have invested tens of millions of dollars in systems and infrastructure at Liberty to enable our customers to manage their illnesses and live healthier lives."

About PolyMedica (www.polymedica.com)

PolyMedica is a rapidly growing national medical products and services company. The Company is best known through its Liberty brand name and innovative direct-to-consumer television advertising to seniors with diabetes and respiratory disease. Building on its technology-based operating platform and compliance management focus, PolyMedica continues to expand its product offerings and services in these chronic disease and other categories. In addition, the Company's AZO line of products addresses female urinary tract discomfort, where it is the market leader. PolyMedica is included in the Russell 2000 and S&P Small Cap 600 indices.

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, outcomes of government inquiries and investigations and related litigation, continued compliance with government regulations, unanticipated regulatory changes, changes in Medicare reimbursement, fluctuations in customer demand, management of rapid growth, intensity of competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions and regulatory changes, as well as other especially relevant risks detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended March 31, 2001, and its Quarterly Reports on Form 10-Q for the periods ended June 30, September 30 and December 31, 2001, and the information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release.